stockportfolio.pro
Stocks / DBD vs WK
DBD vs WK
Diebold Nixdorf, Incorporated and Workiva Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Technology.
| Diebold Nixdorf, Incorporated (DBD) | Workiva Inc. (WK) | |
|---|---|---|
| Market cap | $2.8B | $2.7B |
| Revenue (latest FY) | $3.81B | $884.57M |
| Net income (latest FY) | $94.60M | $-26.17M |
| Revenue growth (5y CAGR) | -0.5% | 20.3% |
| Net margin | 2.5% | -3.0% |
| Return on equity | 8.6% | 481.4% |
| P/E ratio | 27.9 | 201.6 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 1 | 0 |
| Positive free cash flow | — | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open DBD — free Open WK — freeFrequently asked questions
Which is bigger, DBD or WK?
Diebold Nixdorf, Incorporated is larger by market capitalization — $2.8B versus $2.7B.
Which grows faster, DBD or WK?
Over the last five fiscal years, Workiva Inc. grew revenue faster — 20.3%/yr versus -0.5%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.